Daniel Wacker @WackerLab · Oct 16, 2025, Oct 16, 2025, 2:44 AM Our latest work: As it turns out different positive allosteric modulators bind to different sites at the mu opioid receptor. Find out more in our @biorxivpreprint. biorxiv.org/content/10.110…
Daniel Wacker @WackerLab · Aug 13, 2025, Aug 13, 2025, 2:15 PM A take on the current state of biased signaling in psychedelic action and psychedelic drug discovery by John McCorvy and I:Biased Signaling in Psychedelic Action | Annual Reviews - go.shr.lc/4lx1pLf www.annualreviews.org Biased Signaling in Psychedelic Action Psychedelics show tremendous promise for treating psychiatric disorders and other illnesses, including pain and migraine. Despite decades of research, there is uncertainty which signaling mechanisms...
Daniel Wacker @WackerLab · Aug 1, 2025, Aug 1, 2025, 6:10 PM science.org/doi/10.1126/sc… www.science.org Structural determinants of G protein subtype selectivity at the serotonin receptor 5-HT1A Structures reveal how a serotonin receptor binds different G proteins and how an antipsychotic selectively activates one pathway.
Daniel Wacker @WackerLab · Jun 11, 2024, Jun 11, 2024, 7:44 PM Job Alert! Open Postdoc position in membrane protein structural biology, molecular pharmacology @ drug discovery in New York. More info can be found here: wackerlab.com
Daniel Wacker @WackerLab · May 8, 2024, May 8, 2024, 3:42 PM Lessons from a Toad Psychedelic about the Role of different Serotonin Receptors in Psychedelic Physiology: nature.com/articles/s4158…Congrats to Audrey and @LankriDavidIL in this collab with @SamesLab and @ScottRusso published in @Nature